Cargando…

Prevalence of Opioid Dependence and Opioid Agonist Treatment in the Berlin Custodial Setting: A Cross-Sectional Study

BACKGROUND: Among people living in detention, substance use is highly prevalent, including opioid dependence. Opioid agonist treatment (OAT) has been established as an evidence-based, first-line treatment for opioid dependence. Despite high prevalence of opioid dependence, conclusive data regarding...

Descripción completa

Detalles Bibliográficos
Autores principales:	von Bernuth, Kira, Seidel, Peter, Krebs, Julia, Lehmann, Marc, Neumann, Britta, Konrad, Norbert, Opitz-Welke, Annette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435061/ https://www.ncbi.nlm.nih.gov/pubmed/32903474 http://dx.doi.org/10.3389/fpsyt.2020.00794

Ejemplares similares

Availability of opioid agonist treatment and critical incidents in Forensic Clinics for Dependency Diseases in Germany
por: Reiners, Sven, et al.
Publicado: (2022)

Implementation of a Suicide Risk Screening Instrument in a Remand Prison Service in Berlin
por: Dezsö, Dora, et al.
Publicado: (2018)

Foreign National Patients in German Prison Psychiatry
por: Neumann, Britta, et al.
Publicado: (2020)

Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors
por: Shen, Qianwei, et al.
Publicado: (2017)

Editorial: Caring for Those Who Are Neglected and Forgotten: Psychiatry in Prison Environments
por: Opitz-Welke, Annette, et al.
Publicado: (2020)

Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings
por: Dunlop, Adrian J., et al.
Publicado: (2021)

Prison Suicide in Comparison to Suicide Events in Forensic Psychiatric Hospitals in Germany
por: Voulgaris, Alexander, et al.
Publicado: (2018)

Suicide in Older Prisoners in Germany
por: Opitz-Welke, Annette, et al.
Publicado: (2019)

Novel Synthetic Opioids (NSO) Use in Opioid Dependents Entering Detoxification Treatment
por: Specka, Michael, et al.
Publicado: (2022)

The Accessibility of Opioid Agonist Treatment and Its Forced Discontinuation in Swiss Prisons—Attitudes, Perceptions and Experiences of Defense Lawyers in Dealing With Detained Persons Using Opioids
por: Buadze, Anna, et al.
Publicado: (2020)

Identifying Violent Behavior Using the Oxford Mental Illness and Violence Tool in a Psychiatric Ward of a German Prison Hospital
por: Negatsch, Vincent, et al.
Publicado: (2019)

Corrigendum: Violent Behavior During Psychiatric Inpatient Treatment in a German Prison Hospital
por: Seidel, P., et al.
Publicado: (2020)

Violent Behavior During Psychiatric Inpatient Treatment in a German Prison Hospital
por: Seidel, P., et al.
Publicado: (2019)

Negative Impact of Amphetamine-Type Stimulant Use on Opioid Agonist Treatment Retention in Ontario, Canada
por: Morin, Kristen A., et al.
Publicado: (2021)

The four-factor personality model and its qualitative correlates among opioid agonist therapy clients
por: Mahu, Ioan T., et al.
Publicado: (2023)

Management of Opioid Addiction With Opioid Substitution Treatments: Beyond Methadone and Buprenorphine
por: Noble, Florence, et al.
Publicado: (2019)

Dopamine Supersensitivity: A Novel Hypothesis of Opioid-Induced Neurobiological Mechanisms Underlying Opioid-Stimulant Co-use and Opioid Relapse
por: Strickland, Justin C., et al.
Publicado: (2022)

MMPI-2-RF Profiles in Child Custody Litigants
por: Mazza, Cristina, et al.
Publicado: (2019)

Prevalence of alcohol consumption among clients of opioid agonist treatment (OAT) centers in Golestan province, Iran
por: Noroozi, Alireza, et al.
Publicado: (2023)

Chronic Pain Opioid-Maintained Patients Receive Less Analgesic Opioid Prescriptions
por: Delorme, Jessica, et al.
Publicado: (2018)

Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders
por: Burns, Jamie A., et al.
Publicado: (2019)

Anhedonia modulates benzodiazepine and opioid demand among persons in treatment for opioid use disorder
por: Greenwald, Mark K., et al.
Publicado: (2023)

Novel Psychoactive Substances in Custodial Settings: A Mixed Method Investigation on the Experiences of People in Prison and Professionals Working With Them
por: Corazza, Ornella, et al.
Publicado: (2020)

Interactions Between Opioids and Dextroamphetamine on Locomotor Activity: Influence of an Opioid's Relative Efficacy at the Mu Receptor
por: Smith, Mark A., et al.
Publicado: (2022)

In Vitro and In Vivo Profile of PPL-101 and PPL-103: Mixed Opioid Partial Agonist Analgesics with Low Abuse Potential
por: Khroyan, Taline V., et al.
Publicado: (2017)

Peri-Operative Pain and Opioid Use in Opioid-Naïve Patients Following Inpatient Head and Neck Surgery
por: Trakimas, Danielle R., et al.
Publicado: (2022)

Editorial: Current Topics in Opioid Research
por: Toll, Lawrence, et al.
Publicado: (2019)

Operational definition of precipitated opioid withdrawal
por: Dunn, Kelly E., et al.
Publicado: (2023)

EPD1504: a novel μ-opioid receptor partial agonist attenuates obsessive–compulsive disorder (OCD)-like behaviors
por: Youngblood, Beth, et al.
Publicado: (2023)

Opioid Overdose Education for Individuals Prescribed Opioids for Pain Management: Randomized Comparison of Two Computer-Based Interventions
por: Huhn, Andrew S., et al.
Publicado: (2018)

The effects of naltrexone on retention in treatment and being opioid-free in opioid-dependent people: A systematic review and meta-analysis
por: Zangiabadian, Moein, et al.
Publicado: (2022)

Association of prescribed oral stimulants on cocaine use among patients enrolled in opioid agonist treatment: A retrospective longitudinal cohort study
por: Tatangelo, Mark, et al.
Publicado: (2022)

Sexual dysfunction prevalence, risk factors, and help-seeking behavior in opioid agonist treatment and general psychiatry: a cross-sectional study
por: Meyer, Maximilian, et al.
Publicado: (2023)

An Expanding World of Novel Psychoactive Substances: Opioids
por: Zawilska, Jolanta B.
Publicado: (2017)

Sexual Dysfunctions in Patients Receiving Opioid Agonist Treatment and Heroin-Assisted Treatment Compared to Patients in Private Practice—Identifying Group Differences and Predictors
por: Meyer, Maximilian, et al.
Publicado: (2022)

Treatment Outcomes in Patients With Opioid Use Disorder Who Were First Introduced to Opioids by Prescription: A Systematic Review and Meta-Analysis
por: Sanger, Nitika, et al.
Publicado: (2020)

MicroRNA–mRNA networks are dysregulated in opioid use disorder postmortem brain: Further evidence for opioid-induced neurovascular alterations
por: Grimm, Sandra L., et al.
Publicado: (2023)

The Kappa Opioid Receptor: From Addiction to Depression, and Back
por: Lalanne, Laurence, et al.
Publicado: (2014)

Forging Neuroimaging Targets for Recovery in Opioid Use Disorder
por: Stewart, Jennifer L., et al.
Publicado: (2019)

The Costs of Healthcare in Prison and Custody: Systematic Review of Current Estimates and Proposed Guidelines for Future Reporting
por: Sridhar, Shivpriya, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1im5d9ic4ghmuis26mevgk1q2i